Matthew Koster, MD

  • 213 Citations
  • 8 Scopus h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Matthew Koster is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Giant Cell Arteritis Medicine & Life Sciences
Vasculitis Medicine & Life Sciences
Takayasu Arteritis Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Erdheim-Chester Disease Medicine & Life Sciences
Arteritis Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Systemic Vasculitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

2 Citations (Scopus)

Efficacy of methotrexate in real-world management of giant cell arteritis: A case-control study

Koster, M., Yeruva, K., Crowson, C., Muratore, F., Labarca, C. & Warrington, K. J., Jan 1 2019, In : Journal of Rheumatology. 46, 5, p. 501-508 8 p.

Research output: Contribution to journalArticle

Giant Cell Arteritis
Methotrexate
Case-Control Studies
Glucocorticoids
Recurrence

Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014

Ungprasert, P., Koster, M., Cheungpasitporn, W., Wijarnpreecha, K., Thongprayoon, C. & Kroner, P. T., Jan 1 2019, (Accepted/In press) In : Seminars in Arthritis and Rheumatism.

Research output: Contribution to journalArticle

Polyarteritis Nodosa
Comorbidity
Inpatients
Health Expenditures
Length of Stay

Occurrence and aetiology of gastrointestinal perforation in patients with vasculitis

Kronzer, V. L., Larson, D. P., Crowson, C., Warrington, K. J., Ytterberg, S. R., Makol, A. & Koster, M., Mar 1 2019, In : Clinical and experimental rheumatology. 37, 2, p. 32-39 8 p.

Research output: Contribution to journalArticle

Vasculitis
Abdominal Pain
Glucocorticoids
Mortality
Tobacco Use
Erdheim-Chester Disease
Sinus Histiocytosis
Histiocytosis
Langerhans Cell Histiocytosis
Neoplasms
1 Citation (Scopus)

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

Mayo Clinic Histiocytosis Working Group, Apr 4 2019, In : Blood. 133, 14, p. 1607-1610 4 p.

Research output: Contribution to journalLetter

Tumor Burden
Immunotherapy
Tumors
Neoplasms